These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 26921239)
41. Soft targets or partners in health? Retail pharmacies and their role in Tanzania's malaria control program. Kamat VR; Nyato DJ Soc Sci Med; 2010 Aug; 71(3):626-633. PubMed ID: 20621751 [TBL] [Abstract][Full Text] [Related]
42. Adverse event monitoring of artemesinin combination therapy in Nigeria: the challenges and limitations of the study. Oshikoya KA West Afr J Med; 2010; 29(4):221-4. PubMed ID: 20931507 [TBL] [Abstract][Full Text] [Related]
43. Direct observation of outpatient management of malaria in a rural Ghanaian district. Ameme DK; Afari EA; Nyarko KM; Malm KL; Sackey S; Wurapa F Pan Afr Med J; 2014; 19():367. PubMed ID: 25932080 [TBL] [Abstract][Full Text] [Related]
44. Designing adverse event forms for real-world reporting: participatory research in Uganda. Davies EC; Chandler CI; Innocent SH; Kalumuna C; Terlouw DJ; Lalloo DG; Staedke SG; Haaland A PLoS One; 2012; 7(3):e32704. PubMed ID: 22479335 [TBL] [Abstract][Full Text] [Related]
45. Retention and sustainability of community-based health volunteers' activities: A qualitative study in rural Northern Ghana. Chatio S; Akweongo P PLoS One; 2017; 12(3):e0174002. PubMed ID: 28296971 [TBL] [Abstract][Full Text] [Related]
46. Exploring Barriers and Facilitators of Adherence to Artemisinin-Based Combination Therapies for the Treatment of Uncomplicated Malaria in Children in Freetown, Sierra Leone. Banek K; DiLiberto DD; Webb EL; Smith SJ; Chandramohan D; Staedke SG Healthcare (Basel); 2021 Sep; 9(9):. PubMed ID: 34575007 [TBL] [Abstract][Full Text] [Related]
47. Experiences and Lessons From Implementing Cohort Event Monitoring Programmes for Antimalarials in Four African Countries: Results of a Questionnaire-Based Survey. Suku CK; Hill G; Sabblah G; Darko M; Muthuri G; Abwao E; Pandit J; Osakwe AI; Elagbaje C; Nyambayo P; Khoza S; Dodoo AN; Pal SN Drug Saf; 2015 Nov; 38(11):1115-26. PubMed ID: 26267842 [TBL] [Abstract][Full Text] [Related]
48. Re-imagining adherence to treatment from the "other side": local interpretations of adverse anti-malarial drug reactions in the Peruvian Amazon. Muela Ribera J; Hausmann-Muela S; Gryseels C; Peeters Grietens K Malar J; 2016 Mar; 15():136. PubMed ID: 26935955 [TBL] [Abstract][Full Text] [Related]
49. The role of institutions on the effectiveness of malaria treatment in the Ghanaian health sector. Amporfu E; Nonvignon J BMC Health Serv Res; 2015 Apr; 15():169. PubMed ID: 25907582 [TBL] [Abstract][Full Text] [Related]
50. Knowledge and Perceptions about Clinical Trials and the Use of Biomedical Samples: Findings from a Qualitative Study in Rural Northern Ghana. Chatio S; Baiden F; Achana FS; Oduro A; Akazili J PLoS One; 2016; 11(4):e0152854. PubMed ID: 27035916 [TBL] [Abstract][Full Text] [Related]
51. Assessment of adverse drug reactions in the home management of malaria cases of children under 5 years using artemisinin-based combination therapy in Mfou health district, Center region of Cameroon. Bahina LE; Youmba CJ; Mabvouna RB; Sobngwi J J Public Health Afr; 2018 Dec; 9(3):763. PubMed ID: 30687483 [TBL] [Abstract][Full Text] [Related]
52. Parents' perceptions, attitudes and acceptability of treatment of childhood malaria with artemisinin combination therapies in ghana. Adjei GO; Darkwah AK; Goka BQ; Bart-Plange C; Alifrangis ML; Kurtzhals JA; Rodrigues OP Ghana Med J; 2009 Sep; 43(3):99-106. PubMed ID: 20126321 [TBL] [Abstract][Full Text] [Related]
53. Practices of herbal management of malaria among trading mothers in Shai Osudoku District, Accra. Appiah EO; Appiah S; Oti-Boadi E; Oppong-Besse A; Awuah DB; Asiedu PO; Oti-Boateng LE PLoS One; 2022; 17(7):e0271669. PubMed ID: 35849609 [TBL] [Abstract][Full Text] [Related]
54. Factors affecting trust in clinical trials conduct: Views of stakeholders from a qualitative study in Ghana. Chatio ST; Ganle JK; Adongo PB; Beisel U PLOS Glob Public Health; 2023; 3(3):e0001178. PubMed ID: 36963012 [TBL] [Abstract][Full Text] [Related]
55. Patient related factors affecting adherence to antimalarial medication in an urban estate in ghana. Amponsah AO; Vosper H; Marfo AF Malar Res Treat; 2015; 2015():452539. PubMed ID: 25767736 [TBL] [Abstract][Full Text] [Related]
56. Factors Influencing Drug Use Information Received at Primary Healthcare Centre Pharmacies in Ghana. Ansah EW; Menyanu EK Health Serv Insights; 2022; 15():11786329221127140. PubMed ID: 36186736 [TBL] [Abstract][Full Text] [Related]
57. Perceptions, attitudes and acceptance of aretemisinin combination therapy for the treatment of uncomplicated malaria in ghana. Koram KA Ghana Med J; 2009 Sep; 43(3):98. PubMed ID: 20126320 [No Abstract] [Full Text] [Related]
58. Treatments for depression: Side-effects, adverse events and health risks. Kirsch I; Ness AR; Appleton KM J Affect Disord; 2019 Dec; 259():38-39. PubMed ID: 31437699 [No Abstract] [Full Text] [Related]
59. The New Health Act. Hospital (Lond 1886); 1921 Apr; 70(1817):14. PubMed ID: 29830205 [No Abstract] [Full Text] [Related]